EUVIMEDEUVIMED entdecken
Crossref

Botanical Extracts and Compounds of Castanea Plants and Methods of Use: US20190125818A1 - The United States Patent Evaluation

Tatiane Batista Dos Santos iD, Denilson Dos Santos Gomes iD, Agenor Gomes Dos Santos Neto iD, Lívia Maria do Amorim Costa Gaspar iD, Daniela Droppa-Almeida iD

Recent Patents on Biotechnology · 2024

DOI: 10.2174/1872208317666230420105000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Patents on Biotechnology, 2024. Verfasst von Tatiane Batista Dos Santos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Technology and Research, Universidade Tiradentes, Aracaju, Sergipe, Brazil. Hauptthemen laut MEDLINE: Anti-Infective Agents, Bacterial Infections, Acetates. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Council of Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bacterial infections are increasingly difficult to combat, which makes them a threat to public health on a global level. Staphylococcus aureus is considered one of the main causes of infections in hospitals, as it has a variety of virulence factors, as well as is able to produce bacterial biofilms, which, consequently, bring numerous damages to public health as a result of increased resistance to conventional antibiotics and a longer hospital stay. Therefore, the use of compounds extracted from medicinal plants is a potential pharmaceutically acceptable target, as they do not have toxicity and the potential to disrupt biofilms produced by Staphylococcus aureus already evidenced, thus revealing their relevance to our study.

Objective

The objective of this work was to perform a critical analysis of a patent with natural extracts against bacterial biofilms found in the United States Patent and Trademark Office (USPTO) database, to map the possible bioactive compounds that may serve as potential future antimicrobial drugs.

Methods

A technological survey was carried out to verify existing patents using natural extracts with anti-biofilm potential. For this, it was searched with the keywords: Botanical extracts AND biofilms; which were performed in the United States Patent and Trademark Office (USPTO) database. Thus, the selected patent used a non-aqueous extract partitioned and vacuum-contracted, subsequently lyophilized for assays with antimicrobial potential. Because of this, a patent was analyzed regarding its chemistry, and biological activity, followed by a critical analysis of the technology proposed in the invention.

Results

When using the keywords Botanical extracts AND biofilms in the USPTO, it was possible to find twenty-two inventions; however, only four patents in the USPTO were in agreement with the proposal of the natural extract having antimicrobial activity and an anti-biofilm potential, of which two belonged to the same applicant with similar proposals. The key point of this invention was to enable the compounds of the Castanea sativa plant and its methods of obtaining the extract to present a significant antimicrobial action associated or not with antibiotics, promoting the development of new therapies against bacterial infections capable of disrupting biofilms. The invention developed a methodology for extracting Castanea sativa, in which pentacyclic triterpene compounds were found mostly in its leaves. Whereas for the extraction, the crude methanol extracts called extracts 224 from the ground leaves were made by maceration, filtered, combined, concentrated under pressure in rotary evaporators, and lyophilized. After that, they were resuspended in water and partitioned in succession with hexane, ethyl acetate, and butanol. The most active refined partition was the 224C extract with the solvent ethyl acetate, which was subjected to further fractionation using silica column chromatography. Resulting in the most refined extract, which was 224C-F2, capable of acting directly on the quorum sensing of bacteria, mainly Staphylococcus aureus, blocking the translation of RNAIII, including a series of exotoxins. Regarding the antimicrobial capacity against Staphylococcus aureus, it presented Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of 1.56 μg/mL-1 and > 100 μg/mL -1, respectively.

Conclusion

Given the analyzed patent, it was possible to verify the importance of alternatives to reduce the impact of bacterial biofilms, which causes damage to industries in general and to health. From this, the invention analyzed has a promising proposal with antimicrobial potential focusing on the great impact of bacterial biofilms. Therefore, natural extracts with antibiofilmic potential can help to minimize the economic losses caused to health due to these multidrug-resistant microorganisms with different virulence mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Infective AgentsBacterial InfectionsAcetatesHumansPlant ExtractsPatents as TopicAnti-Bacterial AgentsBacteriaMicrobial Sensitivity TestsBiofilms

Stichwörter der Autor:innen

Castanea sativaStaphylococcus aureusUSPTObacterial biofilmsbacterial infectionsmultidrug resistant bacteria

Substanzen

ethyl acetatePlant ExtractsAnti-Bacterial AgentsAnti-Infective AgentsAcetates

Autor:innen und Institutionen

  • Institute of Technology and Research, Universidade Tiradentes, Aracaju, Sergipe, Brazil.

ORCID-Profile: Tatiane Batista Dos Santos, Denilson Dos Santos Gomes, Agenor Gomes Dos Santos Neto, Lívia Maria do Amorim Costa Gaspar, Daniela Droppa-Almeida

Förderung

  • National Council of Research

Zitieren

APA

Dos Santos, T. B., Dos Santos Gomes, D., Dos Santos Neto, A. G., do Amorim Costa Gaspar, L. M., & Droppa-Almeida, D. (2024). Botanical Extracts and Compounds of Castanea Plants and Methods of Use: US20190125818A1 - The United States Patent Evaluation. Recent Patents on Biotechnology. https://doi.org/10.2174/1872208317666230420105000

Vancouver

Dos Santos TB, Dos Santos Gomes D, Dos Santos Neto AG, do Amorim Costa Gaspar LM, Droppa-Almeida D. Botanical Extracts and Compounds of Castanea Plants and Methods of Use: US20190125818A1 - The United States Patent Evaluation. Recent Patents on Biotechnology. 2024. doi:10.2174/1872208317666230420105000

BibTeX
@article{DosSantos2024,
  author = {Dos Santos, Tatiane Batista and Dos Santos Gomes, Denilson and Dos Santos Neto, Agenor Gomes and do Amorim Costa Gaspar, Lívia Maria and Droppa-Almeida, Daniela},
  title = {Botanical Extracts and Compounds of Castanea Plants and Methods of Use: US20190125818A1 - The United States Patent Evaluation},
  journal = {Recent Patents on Biotechnology},
  year = {2024},
  doi = {10.2174/1872208317666230420105000}
}
Kostenlos starten →